Skip to content

Understandable drug information

The effect of a pictogram-guided antihypertensive drug leaflet on patients’ recall and understanding of information, self-efficacy, adherence and blood pressure control.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25593
Enrollment
180
Registered
2015-10-19
Start date
2015-10-28
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

The control group will receive a secondary patient information leaflet that is text-only
the intervention group will receive the same information with pictograms added.

Sponsors

Leiden University Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients who get prescribed antihypertensive medication for the first time, or for the first time after at least a year of not having received this medication.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - unable to verbally communicate in Dutch - blind - under 18 years of age - incapacitated

Design outcomes

Primary

MeasureTime frame
The main study parameter is change in blood pressure control between baseline and the first standard control measurement compared between the control and intervention group.

Secondary

MeasureTime frame
Participants’ use of the leaflet and their perceived comprehensibility, utility and design quality of the leaflet, as well as their recall and understanding of information, self-efficacy, intention to adhere and self-reported adherence will be assessed in the interview and represented by scores that will be compared between the control and intervention group.

Contacts

Public ContactM.M. van Beusekom

Leiden University Medical Center (LUMC)/Leiden University

m.m.van_beusekom@lumc.nl071 527 1886

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)